Clean Fino-Chem Limited, a wholly-owned subsidiary of Clean Science and Technology Limited, has commenced commercial production of Hydroquinone (HQ) and Catechol. This development occurred on Thursday, December 18, 2025, in a dedicated production block. This commercialization marks significant milestones for the company. Clean Science is poised to become a key domestic manufacturer of Hydroquinone and Catechol, contributing to import substitution and potentially driving demand. The introduction of Hydroquinone is expected to enhance the value proposition of the performance segment, creating cross-selling opportunities with MEHQ customers and further strengthening TBHQ market share. Furthermore, the Catechol produced will be captively consumed for the manufacturing of Guaiacol and Veratrole. The successful commercialization of these functionally critical specialty chemicals highlights the company's robust in-house research and development capabilities, supported by its in-house project engineering expertise.